US7125677B2
(en)
*
|
1995-11-13 |
2006-10-24 |
The Salk Institute For Biological Studies |
NIMA interacting proteins
|
US5972697A
(en)
*
|
1995-11-13 |
1999-10-26 |
The Salk Institute For Biological Studies |
NIMA interacting proteins
|
US6277566B1
(en)
*
|
1998-02-13 |
2001-08-21 |
Phillip A. Beachy |
Method for identifying a hedgehog-mediated phosphorylation state dependent transcription factor
|
US20080085515A1
(en)
*
|
2000-03-24 |
2008-04-10 |
Eppendorf Array Technologies Sa (Eat) |
Identification of multiple biological (micro) organisms by detection of their nucleotide sequences on arrays
|
US20070298423A1
(en)
*
|
2000-03-24 |
2007-12-27 |
Eppendorf Array Technologies Sa (Eat) |
Identification of multiple biological (micro) organisms by specific amplification and detection of their nucleotide sequences on arrays
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
US7640484B2
(en)
|
2001-12-28 |
2009-12-29 |
Netapp, Inc. |
Triple parity technique for enabling efficient recovery from triple failures in a storage array
|
EP2258872B1
(en)
*
|
2002-03-13 |
2013-08-14 |
Genomic Health, Inc. |
Gene expression profiling in biopsied tumor tissues
|
US7364846B2
(en)
*
|
2002-10-11 |
2008-04-29 |
Molecular Devices Corporation |
Gene expression profiling from FFPE samples
|
CA2506066A1
(en)
|
2002-11-15 |
2004-06-03 |
Genomic Health, Inc. |
Gene expression profiling of egfr positive cancer
|
US20040231909A1
(en)
|
2003-01-15 |
2004-11-25 |
Tai-Yang Luh |
Motorized vehicle having forward and backward differential structure
|
US20050266409A1
(en)
*
|
2003-02-04 |
2005-12-01 |
Wyeth |
Compositions and methods for diagnosing, preventing, and treating cancers
|
US10533998B2
(en)
|
2008-07-18 |
2020-01-14 |
Bio-Rad Laboratories, Inc. |
Enzyme quantification
|
GB0307428D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Compartmentalised combinatorial chemistry
|
GB0307403D0
(en)
|
2003-03-31 |
2003-05-07 |
Medical Res Council |
Selection by compartmentalised screening
|
US20060078893A1
(en)
|
2004-10-12 |
2006-04-13 |
Medical Research Council |
Compartmentalised combinatorial chemistry by microfluidic control
|
WO2004111603A2
(en)
*
|
2003-05-28 |
2004-12-23 |
Genomic Health, Inc. |
Gene expression markers for predicting response to chemotherapy
|
CN1878866B
(zh)
†
|
2003-07-25 |
2012-08-01 |
安比恩股份有限公司 |
用于从固定的样品中制备rna的方法和组合物
|
DE10344799A1
(de)
*
|
2003-09-26 |
2005-04-14 |
Ganymed Pharmaceuticals Ag |
Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie
|
FR2861744A1
(fr)
*
|
2003-11-05 |
2005-05-06 |
Biomerieux Sa |
Procede pour le pronostic du cancer du sein
|
KR20070000438A
(ko)
*
|
2003-12-23 |
2007-01-02 |
게노믹 헬쓰, 인코포레이티드 |
단편화 rna의 범용적 증폭
|
WO2005067667A2
(en)
*
|
2004-01-07 |
2005-07-28 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to epidermal growth factor receptor modulators
|
US20050221398A1
(en)
*
|
2004-01-16 |
2005-10-06 |
Ipsogen, Sas, A Corporation Of France |
Protein expression profiling and breast cancer prognosis
|
US20070270488A1
(en)
*
|
2004-03-12 |
2007-11-22 |
The Queen's University Of Belfast |
Treatment and Assays
|
US20050221339A1
(en)
|
2004-03-31 |
2005-10-06 |
Medical Research Council Harvard University |
Compartmentalised screening by microfluidic control
|
EP1737980A2
(en)
|
2004-04-09 |
2007-01-03 |
Fondazione IRCCS Istituto Nazionale dei Tumori |
Gene expression markers for predicting response to chemotherapy
|
US20060094035A1
(en)
*
|
2004-06-04 |
2006-05-04 |
Arcturus Bioscience, Inc. |
Identification of tumors
|
US20120258442A1
(en)
|
2011-04-09 |
2012-10-11 |
bio Theranostics, Inc. |
Determining tumor origin
|
EP2272987A3
(en)
*
|
2004-07-09 |
2012-04-11 |
University of Pittsburgh of the Commonwealth System of Higher Education |
Identification of markers in esophageal cancer, colon cancer, head and neck cancer and melanoma
|
DE102004042822A1
(de)
*
|
2004-08-31 |
2006-03-16 |
Technische Universität Dresden |
Verbindungen und Methoden zur Behandlung, Diagnose und Prognose bei Pankreaserkrankungen
|
US7968287B2
(en)
|
2004-10-08 |
2011-06-28 |
Medical Research Council Harvard University |
In vitro evolution in microfluidic systems
|
NZ554895A
(en)
*
|
2004-11-03 |
2009-06-26 |
Almac Diagnostics Ltd |
Transcriptome microarray technology and methods of using the same
|
JP5020088B2
(ja)
*
|
2004-11-05 |
2012-09-05 |
ジェノミック ヘルス, インコーポレイテッド |
遺伝子発現マーカーを使用する、化学療法に対する反応の予測
|
DK1815014T3
(da)
*
|
2004-11-05 |
2012-06-18 |
Genomic Health Inc |
Molekylære indikatorer for brystcancerprognose og forudsigelse af behandlingsrespons
|
US8535914B2
(en)
*
|
2005-01-21 |
2013-09-17 |
Canon Kabushiki Kaisha |
Probe, probe set and information acquisition method using the same
|
DE602006016085D1
(de)
*
|
2005-03-16 |
2010-09-23 |
Genentech Inc |
Biologische marker prediktiv für das ansprechen von krebs auf inhibitoren der kinase des rezeptors für epidermalen wachstumsfaktor
|
US8383357B2
(en)
*
|
2005-03-16 |
2013-02-26 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to epidermal growth factor receptor kinase inhibitors
|
EP1863930A2
(en)
*
|
2005-04-01 |
2007-12-12 |
NCC Technology Ventures Pte Limited |
Materials and methods relating to breast cancer classification
|
US20060246492A1
(en)
*
|
2005-04-05 |
2006-11-02 |
The General Hospital Corporation |
Method for predicting responsiveness to drugs
|
EP1872124A4
(en)
*
|
2005-04-19 |
2008-06-11 |
Prediction Sciences Llc |
DIAGNOSTIC MARKERS FOR THE TREATMENT AND EVOLUTION OF BREAST CANCER AND METHODS OF USE
|
DK1899484T3
(da)
|
2005-06-03 |
2015-11-23 |
Biotheranostics Inc |
Identifikation af tumorer og væv
|
US20070099209A1
(en)
*
|
2005-06-13 |
2007-05-03 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
US8921102B2
(en)
|
2005-07-29 |
2014-12-30 |
Gpb Scientific, Llc |
Devices and methods for enrichment and alteration of circulating tumor cells and other particles
|
US7700299B2
(en)
*
|
2005-08-12 |
2010-04-20 |
Hoffmann-La Roche Inc. |
Method for predicting the response to a treatment
|
ATE520979T1
(de)
*
|
2005-08-24 |
2011-09-15 |
Bristol Myers Squibb Co |
Biomarker und verfahren zur bestimmung der empfindlichkeit gegenüber modulatoren des egf(epidermal growth factor)-rezeptors
|
JP2009507496A
(ja)
*
|
2005-09-09 |
2009-02-26 |
ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム |
エストロゲン受容体(er)遺伝子およびer関連遺伝子のゲノム発現の算出された指標
|
EP1946114A4
(en)
*
|
2005-09-21 |
2010-05-26 |
Ccc Diagnostics Llc |
EXHAUSTIVE DIAGNOSTIC TEST PROCEDURES FOR PERSONALIZED ANTICANCER CHEMOTHERAPIES
|
JP5129149B2
(ja)
|
2005-10-31 |
2013-01-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
癌を処置および診断するための組成物および方法
|
WO2007067500A2
(en)
*
|
2005-12-05 |
2007-06-14 |
Genomic Health, Inc. |
Predictors of patient response to treatment with egfr inhibitors
|
CA2633754C
(en)
*
|
2006-01-05 |
2013-06-18 |
The Ohio State University Research Foundation |
Microrna-based methods and compositions for the diagnosis and treatment of solid cancers
|
WO2007081386A2
(en)
|
2006-01-11 |
2007-07-19 |
Raindance Technologies, Inc. |
Microfluidic devices and methods of use
|
SG169395A1
(en)
|
2006-02-09 |
2011-03-30 |
Univ South Florida |
Detection of cancer by elevated levels of bcl-2
|
WO2007123772A2
(en)
*
|
2006-03-31 |
2007-11-01 |
Genomic Health, Inc. |
Genes involved in estrogen metabolism
|
CN101240331A
(zh)
*
|
2006-04-07 |
2008-08-13 |
甄二真 |
基于mEPHX基因多态性的皮肤美容保健方法
|
US20070254305A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Nsabp Foundation, Inc. |
Methods of whole genome or microarray expression profiling using nucleic acids prepared from formalin fixed paraffin embedded tissue
|
US9562837B2
(en)
|
2006-05-11 |
2017-02-07 |
Raindance Technologies, Inc. |
Systems for handling microfludic droplets
|
US20080014589A1
(en)
|
2006-05-11 |
2008-01-17 |
Link Darren R |
Microfluidic devices and methods of use thereof
|
US8768629B2
(en)
*
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
IL282783B2
(en)
|
2006-05-18 |
2023-09-01 |
Caris Mpi Inc |
A system and method for determining a personalized medical intervention for a disease stage
|
US20080070792A1
(en)
|
2006-06-14 |
2008-03-20 |
Roland Stoughton |
Use of highly parallel snp genotyping for fetal diagnosis
|
US8137912B2
(en)
|
2006-06-14 |
2012-03-20 |
The General Hospital Corporation |
Methods for the diagnosis of fetal abnormalities
|
EP2589668A1
(en)
|
2006-06-14 |
2013-05-08 |
Verinata Health, Inc |
Rare cell analysis using sample splitting and DNA tags
|
US20080050739A1
(en)
*
|
2006-06-14 |
2008-02-28 |
Roland Stoughton |
Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats
|
US20100003189A1
(en)
*
|
2006-07-14 |
2010-01-07 |
The Regents Of The University Of California |
Cancer biomarkers and methods of use thereof
|
EP2077912B1
(en)
|
2006-08-07 |
2019-03-27 |
The President and Fellows of Harvard College |
Fluorocarbon emulsion stabilizing surfactants
|
US20080118576A1
(en)
*
|
2006-08-28 |
2008-05-22 |
Dan Theodorescu |
Prediction of an agent's or agents' activity across different cells and tissue types
|
US20080096208A1
(en)
*
|
2006-09-06 |
2008-04-24 |
Connors Richard W |
Biomarkers for assessing response to c-met treatment
|
US7615349B2
(en)
*
|
2006-09-07 |
2009-11-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Melanoma gene signature
|
EP2081950B1
(en)
*
|
2006-09-21 |
2013-03-20 |
Nuclea Biomarkers LLC |
Expression profiles associated with irinotecan treatment
|
JP5041580B2
(ja)
*
|
2006-10-17 |
2012-10-03 |
一般財団法人化学及血清療法研究所 |
仲介ポリヌクレオチド
|
US20080125358A1
(en)
*
|
2006-10-26 |
2008-05-29 |
University Of Massachusetts Medical School |
Methods for Chk2 inhibitor patient selection
|
KR100862972B1
(ko)
|
2006-10-30 |
2008-10-13 |
한국과학기술연구원 |
휘발성 유기 화합물 검색용 바이오마커 및 이를 이용한유해성을 나타내는 휘발성 유기 화합물 검색 방법
|
WO2008063521A2
(en)
*
|
2006-11-13 |
2008-05-29 |
The General Hospital Corporation |
Gene-based clinical scoring system
|
KR100886670B1
(ko)
|
2007-01-11 |
2009-03-04 |
김현기 |
유두갑상선암의 새로운 진단마커 및 진단방법
|
WO2008092002A2
(en)
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
US8772046B2
(en)
|
2007-02-06 |
2014-07-08 |
Brandeis University |
Manipulation of fluids and reactions in microfluidic systems
|
US20100234381A1
(en)
*
|
2007-04-13 |
2010-09-16 |
Bristol-Myers Squibb Company |
Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
|
JP5240739B2
(ja)
*
|
2007-04-13 |
2013-07-17 |
オーエスアイ・フアーマシユーテイカルズ・エル・エル・シー |
キナーゼ阻害剤に対する抗癌応答を予測する生物学的マーカー
|
US8592221B2
(en)
|
2007-04-19 |
2013-11-26 |
Brandeis University |
Manipulation of fluids, fluid components and reactions in microfluidic systems
|
WO2008150937A2
(en)
*
|
2007-05-29 |
2008-12-11 |
Aivaradx, Inc. |
Real-time pcr
|
AU2008260075A1
(en)
|
2007-05-31 |
2008-12-11 |
California Pacific Medical Center |
Method to predict or diagnose a gastrointestinal disorder or disease
|
WO2008154249A2
(en)
|
2007-06-08 |
2008-12-18 |
Genentech, Inc. |
Gene expression markers of tumor resistance to her2 inhibitor treatment
|
US9551033B2
(en)
|
2007-06-08 |
2017-01-24 |
Genentech, Inc. |
Gene expression markers of tumor resistance to HER2 inhibitor treatment
|
CN101918424A
(zh)
|
2007-06-15 |
2010-12-15 |
俄亥俄州立大学研究基金会 |
用于靶向由Drosha介导的微小RNA加工的致癌ALL-1融合蛋白
|
US8883440B2
(en)
|
2007-07-26 |
2014-11-11 |
Nancy M. Lee |
Method to predict or diagnose a gastrointestinal disorder or disease
|
EP2173908B1
(en)
|
2007-08-03 |
2016-01-06 |
The Ohio State University Research Foundation |
Ultraconserved regions encoding ncrnas
|
AU2008289148A1
(en)
*
|
2007-08-16 |
2009-02-26 |
Aventis Inc. |
Gene expression markers of recurrence risk in cancer patients after chemotherapy
|
US8921114B2
(en)
|
2007-08-24 |
2014-12-30 |
Sysmex Corporation |
Diagnosis support system for cancer, diagnosis support information providing method for cancer, and computer program product
|
WO2009036427A2
(en)
*
|
2007-09-14 |
2009-03-19 |
Ventana Medical Systems, Inc. |
Prostate cancer biomarkers
|
US9388457B2
(en)
|
2007-09-14 |
2016-07-12 |
Affymetrix, Inc. |
Locus specific amplification using array probes
|
US8716190B2
(en)
|
2007-09-14 |
2014-05-06 |
Affymetrix, Inc. |
Amplification and analysis of selected targets on solid supports
|
US8048621B2
(en)
|
2007-10-03 |
2011-11-01 |
OSI Pharmaceuticals, LLC |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
WO2009045361A2
(en)
|
2007-10-03 |
2009-04-09 |
Osi Pharmaceuticals, Inc. |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
WO2009048901A1
(en)
*
|
2007-10-09 |
2009-04-16 |
University Of Washington |
Quantitative/semi-quantitative measurement of epor on cancer cells
|
WO2009052286A1
(en)
*
|
2007-10-16 |
2009-04-23 |
Ventana Medical Systems, Inc. |
Grading, staging, and prognosing cancer using osteopontin-c
|
WO2009055559A1
(en)
*
|
2007-10-23 |
2009-04-30 |
University Of South Florida |
Method of predicting chemotherapeutic responsiveness of cancer
|
CN103898069A
(zh)
|
2007-10-26 |
2014-07-02 |
俄亥俄州立大学研究基金会 |
鉴定脆性组氨酸三联体(Fhit)相互作用的方法及其用途
|
EP2065473A1
(en)
*
|
2007-11-28 |
2009-06-03 |
Siemens Healthcare Diagnostics GmbH |
A method to assess prognosis and to predict therapeutic success in gynecologic cancer
|
WO2009068423A2
(en)
|
2007-11-30 |
2009-06-04 |
Siemens Healthcare Diagnostics Gmbh |
Method for predicting therapy responsiveness in basal like tumors
|
US8476420B2
(en)
*
|
2007-12-05 |
2013-07-02 |
The Wistar Institute Of Anatomy And Biology |
Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
|
US10416162B2
(en)
|
2007-12-20 |
2019-09-17 |
Monogram Biosciences, Inc. |
Her2 diagnostic methods
|
DK2294215T3
(da)
|
2008-05-12 |
2013-04-22 |
Genomic Health Inc |
Tests til forudsigelse af cancerpatienters respons på forskellige kemoterapeutiske behandlingsmuligheder
|
AU2009246398A1
(en)
*
|
2008-05-14 |
2009-11-19 |
Bristol-Myers Squibb Company |
Predictors of patient response to treatment with EGF receptor inhibitors
|
US20110318732A1
(en)
*
|
2008-05-28 |
2011-12-29 |
Singer Robert H |
Prediction of chemotherapeutic response via single-cell profiling of transcription site activation
|
CN102149827B
(zh)
|
2008-06-11 |
2014-08-20 |
由卫生与公众服务部代表的美利坚合众国政府 |
MiR-26家族作为肝细胞癌和对治疗的应答性的预测性标志物的用途
|
BRPI0812682A2
(pt)
|
2008-06-16 |
2010-06-22 |
Genentech Inc |
tratamento de cáncer de mama metastático
|
WO2010009365A1
(en)
|
2008-07-18 |
2010-01-21 |
Raindance Technologies, Inc. |
Droplet libraries
|
WO2010028288A2
(en)
|
2008-09-05 |
2010-03-11 |
Aueon, Inc. |
Methods for stratifying and annotating cancer drug treatment options
|
US10359425B2
(en)
*
|
2008-09-09 |
2019-07-23 |
Somalogic, Inc. |
Lung cancer biomarkers and uses thereof
|
SI2334812T1
(sl)
|
2008-09-20 |
2017-05-31 |
The Board of Trustees of the Leland Stanford Junior University Office of the General Counsel Building 170 |
Neinvazivna diagnoza fetalne anevploidije s sekvenciranjem
|
US9186128B2
(en)
|
2008-10-01 |
2015-11-17 |
Covidien Lp |
Needle biopsy device
|
US9782565B2
(en)
|
2008-10-01 |
2017-10-10 |
Covidien Lp |
Endoscopic ultrasound-guided biliary access system
|
US11298113B2
(en)
|
2008-10-01 |
2022-04-12 |
Covidien Lp |
Device for needle biopsy with integrated needle protection
|
US8968210B2
(en)
|
2008-10-01 |
2015-03-03 |
Covidien LLP |
Device for needle biopsy with integrated needle protection
|
US9332973B2
(en)
|
2008-10-01 |
2016-05-10 |
Covidien Lp |
Needle biopsy device with exchangeable needle and integrated needle protection
|
US20100221752A2
(en)
*
|
2008-10-06 |
2010-09-02 |
Somalogic, Inc. |
Ovarian Cancer Biomarkers and Uses Thereof
|
CN106153918A
(zh)
*
|
2008-10-14 |
2016-11-23 |
卡里斯Mpi公司 |
描绘肿瘤类型生物标志模式和特征集的基因靶和基因表达的蛋白靶
|
EP2722400A3
(en)
*
|
2008-10-29 |
2014-07-09 |
William Beaumont Hospital |
Methods of using biomarkers
|
WO2010056337A2
(en)
|
2008-11-12 |
2010-05-20 |
Caris Mpi, Inc. |
Methods and systems of using exosomes for determining phenotypes
|
WO2010065568A2
(en)
|
2008-12-01 |
2010-06-10 |
Laboratory Corporation Of America Holdings |
METHODS AND ASSAYS FOR MEASURING p95 AND/OR p95 IN A SAMPLE AND ANTIBODIES SPECIFIC FOR p95
|
US20120041274A1
(en)
|
2010-01-07 |
2012-02-16 |
Myriad Genetics, Incorporated |
Cancer biomarkers
|
US20100233732A1
(en)
*
|
2009-01-15 |
2010-09-16 |
Laboratory Corporation Of America Holdings |
Methods of Determining Patient Response By Measurement of HER-2 Expression
|
ES2535723T3
(es)
|
2009-01-15 |
2015-05-14 |
Laboratory Corporation Of America Holdings |
Métodos de determinación de la respuesta del paciente mediante la medición de Her-3
|
WO2010099137A2
(en)
*
|
2009-02-26 |
2010-09-02 |
Osi Pharmaceuticals, Inc. |
In situ methods for monitoring the emt status of tumor cells in vivo
|
US8528589B2
(en)
|
2009-03-23 |
2013-09-10 |
Raindance Technologies, Inc. |
Manipulation of microfluidic droplets
|
EP2425021A4
(en)
*
|
2009-05-01 |
2013-03-06 |
Nuvera Biosciences Inc |
INDEX OF GENOMEXPRESSION OF ESTROGEN RECEPTOR (ER) AND ER-ASSOCIATED GENES
|
WO2010135411A2
(en)
*
|
2009-05-19 |
2010-11-25 |
The Regents Of The University Of Colorado |
Aurora-a copy number and sensitivity to inhibitors
|
EP2278026A1
(en)
*
|
2009-07-23 |
2011-01-26 |
Université de la Méditerranée |
A method for predicting clinical outcome of patients with breast carcinoma
|
EP2475988B1
(en)
|
2009-09-09 |
2018-11-14 |
The General Hospital Corporation |
Use of microvesicles in analyzing nucleic acid profiles
|
US8563261B2
(en)
|
2009-09-28 |
2013-10-22 |
The Trustees Of The University Of Pennsylvania |
Method of diagnosing and treating interstitial cystitis
|
EP2486409A1
(en)
|
2009-10-09 |
2012-08-15 |
Universite De Strasbourg |
Labelled silica-based nanomaterial with enhanced properties and uses thereof
|
US7736861B1
(en)
*
|
2009-10-19 |
2010-06-15 |
Aveo Pharmaceuticals, Inc. |
Tivozanib response prediction
|
US8916533B2
(en)
|
2009-11-23 |
2014-12-23 |
The Ohio State University |
Materials and methods useful for affecting tumor cell growth, migration and invasion
|
DK2504451T3
(da)
*
|
2009-11-23 |
2019-08-05 |
Genomic Health Inc |
Fremgangsmåder til at forudsige det kliniske forløb af cancer
|
US20110129822A1
(en)
*
|
2009-12-01 |
2011-06-02 |
Precision Therapeutics, Inc. |
Multi drug response markers for breast cancer cells
|
US10837883B2
(en)
|
2009-12-23 |
2020-11-17 |
Bio-Rad Laboratories, Inc. |
Microfluidic systems and methods for reducing the exchange of molecules between droplets
|
NZ600268A
(en)
|
2010-01-11 |
2014-08-29 |
Genomic Health Inc |
Method to use gene expression to determine likelihood of clinical outcome of renal cancer
|
WO2011088137A2
(en)
*
|
2010-01-12 |
2011-07-21 |
H. Lee Moffitt Cancer Center & Research Institute |
Bad pathway gene signature
|
WO2011100604A2
(en)
|
2010-02-12 |
2011-08-18 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US9366632B2
(en)
|
2010-02-12 |
2016-06-14 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US10351905B2
(en)
|
2010-02-12 |
2019-07-16 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
US9399797B2
(en)
|
2010-02-12 |
2016-07-26 |
Raindance Technologies, Inc. |
Digital analyte analysis
|
US20130143753A1
(en)
*
|
2010-03-01 |
2013-06-06 |
Adelbio |
Methods for predicting outcome of breast cancer, and/or risk of relapse, response or survival of a patient suffering therefrom
|
JP5808349B2
(ja)
|
2010-03-01 |
2015-11-10 |
カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー |
セラノーシスのためのバイオマーカー
|
WO2011109637A1
(en)
*
|
2010-03-03 |
2011-09-09 |
Koo Foundation Sun Yat-Sen Cancer Center |
Methods for classifying and treating breast cancers
|
US20110217309A1
(en)
*
|
2010-03-03 |
2011-09-08 |
Buck Elizabeth A |
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
|
JP5553661B2
(ja)
*
|
2010-03-30 |
2014-07-16 |
シスメックス株式会社 |
癌の再発リスク判定方法
|
US8597201B2
(en)
|
2010-03-30 |
2013-12-03 |
Siteselect Medical Technologies, Inc. |
Tissue excision device with a flexible transection blade
|
WO2011122859A2
(ko)
*
|
2010-03-30 |
2011-10-06 |
서울대학교 산학협력단 |
뇌종양의 재발 가능성 및 생존 예후 예측용 조성물 및 이를 포함하는 키트
|
BR112012025593A2
(pt)
|
2010-04-06 |
2019-06-25 |
Caris Life Sciences Luxembourg Holdings |
biomarcadores em circulação para doença
|
EP3508854A1
(en)
*
|
2010-04-27 |
2019-07-10 |
The Regents of The University of California |
Cancer biomarkers and methods of use thereof
|
CA2800684A1
(en)
*
|
2010-05-26 |
2011-12-01 |
Expression Pathology, Inc. |
Urokinase-type plasminogen activator protein/plasminogen activator inhibitor type-1 protein selected reaction monitoring assay
|
CA2804391A1
(en)
|
2010-07-07 |
2012-01-12 |
Myriad Genetics, Inc. |
Gene signatures for cancer prognosis
|
SG186953A1
(en)
|
2010-07-09 |
2013-02-28 |
Somalogic Inc |
Lung cancer biomarkers and uses thereof
|
DE102010033575B4
(de)
|
2010-08-02 |
2016-01-14 |
Eberhard-Karls-Universität Tübingen Universitätsklinikum |
ASPP2-Splicevariante
|
CN106198980B
(zh)
|
2010-08-13 |
2018-09-07 |
私募蛋白质体公司 |
胰腺癌生物标记及其用途
|
EP2611941A4
(en)
|
2010-08-30 |
2014-01-22 |
Myriad Genetics Inc |
GENESIS OF CANCER DIAGNOSIS AND PROGNOSIS
|
EP3447155A1
(en)
|
2010-09-30 |
2019-02-27 |
Raindance Technologies, Inc. |
Sandwich assays in droplets
|
WO2012065049A1
(en)
|
2010-11-12 |
2012-05-18 |
The Ohio State University Research Foundation |
Materials and methods related to microrna-21, mismatch repair, and colorectal cancer
|
CN103313706A
(zh)
|
2010-11-15 |
2013-09-18 |
俄亥俄州立大学研究基金会 |
控制释放粘膜粘合系统
|
WO2012090073A2
(en)
*
|
2010-12-30 |
2012-07-05 |
The Netherlands Cancer Institute |
Methods and compositions for predicting chemotherapy sensitivity
|
WO2012097368A2
(en)
*
|
2011-01-14 |
2012-07-19 |
Response Genetics, Inc. |
Her3 and her4 primers and probes for detecting her3 and her4 mrna expression
|
WO2012109233A2
(en)
*
|
2011-02-07 |
2012-08-16 |
Board Of Regents, The University Of Texas System |
Methods for predicting recurrence risk in breast cancer patients
|
WO2012109600A2
(en)
|
2011-02-11 |
2012-08-16 |
Raindance Technologies, Inc. |
Methods for forming mixed droplets
|
WO2012112804A1
(en)
|
2011-02-18 |
2012-08-23 |
Raindance Technoligies, Inc. |
Compositions and methods for molecular labeling
|
EP2683387A4
(en)
|
2011-03-07 |
2014-09-03 |
Univ Ohio State |
MUTATORY ACTIVITY INDUCED BY INFLAMMATION OF MICROARN-155 (MIR-155) BINDING AND CANCER
|
WO2012149014A1
(en)
|
2011-04-25 |
2012-11-01 |
OSI Pharmaceuticals, LLC |
Use of emt gene signatures in cancer drug discovery, diagnostics, and treatment
|
US8841071B2
(en)
|
2011-06-02 |
2014-09-23 |
Raindance Technologies, Inc. |
Sample multiplexing
|
WO2013006502A1
(en)
*
|
2011-07-01 |
2013-01-10 |
Pinpoint Genomics, Inc. |
Method for extracting rna from fixed embedded tissue
|
EP2744916A4
(en)
|
2011-07-13 |
2015-06-17 |
Primeradx Inc |
MULTIMODAL METHODS FOR SIMULTANEOUS DETECTION AND QUANTIFICATION OF MULTIPLE NUCLEIC ACIDS IN A SAMPLE
|
US8658430B2
(en)
|
2011-07-20 |
2014-02-25 |
Raindance Technologies, Inc. |
Manipulating droplet size
|
GB201114919D0
(en)
*
|
2011-08-30 |
2011-10-12 |
Glaxosmithkline Biolog Sa |
Method
|
CN102533740B
(zh)
*
|
2011-09-07 |
2013-07-24 |
杭州艾迪康医学检验中心有限公司 |
人白血病融合基因bcr-abl的rt-pcr引物及其使用方法
|
EP2766500A4
(en)
|
2011-10-14 |
2015-10-14 |
Univ Ohio State |
METHODS AND MATERIALS RELATED TO OVARIAN CANCER
|
WO2013070521A1
(en)
*
|
2011-11-08 |
2013-05-16 |
Genomic Health, Inc. |
Method of predicting breast cancer prognosis
|
CN103145845A
(zh)
*
|
2011-12-06 |
2013-06-12 |
吉林圣元科技有限责任公司 |
Tat与人野生型P53融合蛋白在毕赤酵母中的表达
|
US9481885B2
(en)
|
2011-12-13 |
2016-11-01 |
Ohio State Innovation Foundation |
Methods and compositions related to miR-21 and miR-29a, exosome inhibition, and cancer metastasis
|
EP2804960A4
(en)
|
2012-01-20 |
2015-08-19 |
Univ Ohio State |
BREAST CANCER BIOMARK SIGNATURES FOR INVASIVITY AND FORECAST
|
WO2013120089A1
(en)
|
2012-02-10 |
2013-08-15 |
Raindance Technologies, Inc. |
Molecular diagnostic screening assay
|
WO2013165748A1
(en)
|
2012-04-30 |
2013-11-07 |
Raindance Technologies, Inc |
Digital analyte analysis
|
JP6352909B2
(ja)
|
2012-06-27 |
2018-07-04 |
バーグ エルエルシー |
前立腺癌の診断および処置におけるマーカーの使用
|
EP4190918A1
(en)
|
2012-11-16 |
2023-06-07 |
Myriad Genetics, Inc. |
Gene signatures for cancer prognosis
|
US20140186468A1
(en)
*
|
2012-12-07 |
2014-07-03 |
Susana Gonzalo |
Diagnosing subsets of triple-negative breast cancer
|
CA2896899A1
(en)
|
2013-01-18 |
2014-07-24 |
Ellis KLINE |
Selective glycosidase regimen for immune programming and treatment of cancer
|
WO2014124454A1
(en)
|
2013-02-11 |
2014-08-14 |
Katerina Gurova |
Use of facilitates chromatin transcription complex (fact) in cancer
|
EP2986762B1
(en)
|
2013-04-19 |
2019-11-06 |
Bio-Rad Laboratories, Inc. |
Digital analyte analysis
|
WO2014190090A1
(en)
*
|
2013-05-21 |
2014-11-27 |
Dignity Health |
Genetic signature of vulnerability to inhibitors of base excision repair (ber) in cancer
|
DK3004392T3
(da)
|
2013-05-30 |
2020-10-26 |
Genomic Health Inc |
Genekspressionsprofilalgoritme til beregning af en recidivscore for en patient med nyrecancer
|
WO2015048098A1
(en)
|
2013-09-24 |
2015-04-02 |
Washington University |
Diagnostic methods for infectious disease using endogenous gene expression
|
US11901041B2
(en)
|
2013-10-04 |
2024-02-13 |
Bio-Rad Laboratories, Inc. |
Digital analysis of nucleic acid modification
|
US9944977B2
(en)
|
2013-12-12 |
2018-04-17 |
Raindance Technologies, Inc. |
Distinguishing rare variations in a nucleic acid sequence from a sample
|
EP3090063B1
(en)
|
2013-12-31 |
2019-11-06 |
Bio-Rad Laboratories, Inc. |
Method for detection of latent retrovirus
|
EP3623482A1
(en)
|
2014-05-13 |
2020-03-18 |
Myriad Genetics, Inc. |
Gene signatures for cancer prognosis
|
WO2015187612A1
(en)
|
2014-06-02 |
2015-12-10 |
Valley Health System |
Method and systems for lung cancer diagnosis
|
US9994912B2
(en)
|
2014-07-03 |
2018-06-12 |
Abbott Molecular Inc. |
Materials and methods for assessing progression of prostate cancer
|
EP3207370B1
(en)
|
2014-10-17 |
2019-04-17 |
Assistance Publique-Hôpitaux de Paris |
Methods for the monitoring and prognosis of a bladder cancer
|
AU2015334842B2
(en)
|
2014-10-24 |
2022-02-17 |
Koninklijke Philips N.V. |
Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities
|
CA2965217A1
(en)
|
2014-10-24 |
2016-04-28 |
Koninklijke Philips N.V. |
Medical prognosis and prediction of treatment response using multiple cellular signaling pathway activities
|
ES2833543T3
(es)
|
2014-10-24 |
2021-06-15 |
Koninklijke Philips Nv |
Evaluación de la actividad de la ruta de señalización celular de TGF usando modelos matemáticos de la expresión de genes diana
|
US11543411B2
(en)
|
2014-12-05 |
2023-01-03 |
Prelude Corporation |
DCIS recurrence and invasive breast cancer
|
CA2970143A1
(en)
|
2014-12-08 |
2016-06-16 |
Berg Llc |
Use of markers including filamin a in the diagnosis and treatment of prostate cancer
|
AU2016302344A1
(en)
|
2015-08-06 |
2018-03-08 |
The Wistar Institute Of Anatomy And Biology |
Combination therapies targeting mitochondrial biogenesis for cancer therapy
|
CN108138237B
(zh)
|
2015-08-14 |
2022-04-05 |
皇家飞利浦有限公司 |
使用靶基因表达的数学建模评估NFkB细胞信号传导途径活性
|
US10647981B1
(en)
|
2015-09-08 |
2020-05-12 |
Bio-Rad Laboratories, Inc. |
Nucleic acid library generation methods and compositions
|
US11661632B2
(en)
|
2016-06-21 |
2023-05-30 |
The Wistar Institute Of Anatomy And Biology |
Compositions and methods for diagnosing lung cancers using gene expression profiles
|
US10487365B2
(en)
|
2016-09-20 |
2019-11-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods for detecting expression of lnc-FANCI-2 in cervical cells
|
US11229662B2
(en)
|
2016-11-15 |
2022-01-25 |
The Schepens Eye Research Institute, Inc. |
Compositions and methods for the treatment of aberrant angiogenesis
|
KR101950717B1
(ko)
*
|
2016-11-23 |
2019-02-21 |
주식회사 젠큐릭스 |
유방암 환자의 화학치료 유용성 예측 방법
|
US10636512B2
(en)
|
2017-07-14 |
2020-04-28 |
Cofactor Genomics, Inc. |
Immuno-oncology applications using next generation sequencing
|
US10998178B2
(en)
|
2017-08-28 |
2021-05-04 |
Purdue Research Foundation |
Systems and methods for sample analysis using swabs
|
EP3461915A1
(en)
|
2017-10-02 |
2019-04-03 |
Koninklijke Philips N.V. |
Assessment of jak-stat1/2 cellular signaling pathway activity using mathematical modelling of target gene expression
|
CA3082643A1
(en)
|
2017-11-14 |
2019-05-23 |
The Schepens Eye Research Institute, Inc. |
Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
|
EP3502279A1
(en)
|
2017-12-20 |
2019-06-26 |
Koninklijke Philips N.V. |
Assessment of mapk-ap 1 cellular signaling pathway activity using mathematical modelling of target gene expression
|
CN110045120A
(zh)
*
|
2018-01-15 |
2019-07-23 |
长庚医疗财团法人基隆长庚纪念医院 |
检测生物样品中wisp1的浓度在制备用于乳癌筛检及侦测复发的检测试剂盒及其应用
|
WO2020056162A1
(en)
*
|
2018-09-12 |
2020-03-19 |
Oregon Health & Science University |
Detecting and/or subtyping circulating hybrid cells that correlate with stage and survival
|
WO2020056338A1
(en)
|
2018-09-14 |
2020-03-19 |
Prelude Corporation |
Method of selection for treatment of subjects at risk of invasive breast cancer
|
WO2020178399A1
(en)
|
2019-03-05 |
2020-09-10 |
Norwegian University Of Science And Technology (Ntnu) |
Breast cancer signature genes
|
EP4097479A4
(en)
*
|
2020-01-30 |
2023-12-20 |
Arocell AB |
PREDICTING PATIENT SURVIVAL
|
EP4326270A1
(en)
*
|
2021-04-21 |
2024-02-28 |
Apollomics Inc. |
Diagnostic and treatment of cancer using c-met inhibitor
|
EP4253567A1
(en)
*
|
2022-03-31 |
2023-10-04 |
OncoAssure Limited |
A method of predicting risk of an aggressive or recurrent cancer
|